A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

[1] Adler LA(2008)Functional outcomes in the treatment of adults with ADHD J Atten Disord 11 720-727

[2] Spencer TJ(2006)Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guidelines Eur Child Adolesc Psychiatry 15 476-495

[3] Levine LR(2006)A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder Biol Psychiatry 59 829-835

[4] Ramsey JL(2003)The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder Can J Psychiatry 48 546-554

[5] Tamura R(2003)ADHD in adulthood–guidelines based on expert consensus with DGPPN support Nervenarzt 74 939-946

[6] Kelsey D(2004)Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder J Clin Psychopharmacol 24 24-29

[7] Ball SG(2007)Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder Brit J Psychiatry 190 402-409

[8] Allen AJ(1985)Attention deficit disorders in adults Clin Neuropharmacol 8 343-356

[9] Biederman J(2007)Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study J Clin Psychiatry 68 268-277

[10] Banaschewski T(2004)Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial Psychol Med 34 973-982

[1] Adler LA(2008)Functional outcomes in the treatment of adults with ADHD J Atten Disord 11 720-727

[2] Spencer TJ(2006)Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guidelines Eur Child Adolesc Psychiatry 15 476-495

[3] Levine LR(2006)A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder Biol Psychiatry 59 829-835

[4] Ramsey JL(2003)The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder Can J Psychiatry 48 546-554

[5] Tamura R(2003)ADHD in adulthood–guidelines based on expert consensus with DGPPN support Nervenarzt 74 939-946

[6] Kelsey D(2004)Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder J Clin Psychopharmacol 24 24-29

[7] Ball SG(2007)Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder Brit J Psychiatry 190 402-409

[8] Allen AJ(1985)Attention deficit disorders in adults Clin Neuropharmacol 8 343-356

[9] Biederman J(2007)Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study J Clin Psychiatry 68 268-277

[10] Banaschewski T(2004)Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial Psychol Med 34 973-982